Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lanreotide acetate
- Development stage
- Approved
- Lead developer
- Nal Pharmaceuticals
- Modality
- Peptides
- Administration
- Subcutaneous, Intramuscular
01
Overview
NAL1868 is a peptide-based therapeutic candidate containing lanreotide acetate, a synthetic analog of the natural hormone somatostatin. Developed by NAL Pharmaceutical Group, NAL1868 is designed as an injectable formulation for use in supportive oncology and cancer treatment. As a somatostatin receptor agonist, it primarily targets somatostatin receptor type 2 (SSTR2) and somatostatin receptor type 5 (SSTR5), leading to the inhibition of various endocrine and exocrine secretions, including growth hormone and insulin-like growth factor 1 (IGF-1). The program is currently in the preclinical stage of development, leveraging NAL Pharmaceutical's expertise in drug delivery systems to optimize the therapeutic profile of the peptide.
- Other names
- lanreotide
02
Targets
SSTR2 (Somatostatin receptor type 2)SSTR5 (Somatostatin receptor 5)
Beyond the preview
Go deeper on lanreotide acetate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lanreotide acetate.